To sum up, our study demonstrated that the mutation in the MTOR gene might increase the risk of PD, and the mutation in the receptor subtype of Nogo‐associated genes might reduce the risk of PD, which enlarged the genetic spectrum of the Nogo‐associated genes. This evidence concerns the gene RTN4 and Parkinson disease.